肠易激综合症治疗市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00006814
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 180
Buy Now

2020年肠易激综合症(IBS)治疗市场价值为21.5389亿美元,预计到2028年将达到46.003亿美元;预计2021年至2028年复合年增长率为10.1%。

肠易激综合征疾病患病率不断上升以及研究和研究不断增加等主要因素。开发活动推动市场增长。然而,产品数量有限和处理效率低下限制了市场增长。 IBS 是一种常见的慢性疾病,影响腹部器官大肠。它也被称为痉挛性结肠、粘液性结肠炎、结肠激惹和痉挛性结肠炎。这种情况与炎症性肠病有很大不同。它会出现痉挛、腹痛、腹胀、胀气、腹泻或便秘等症状,或者同时出现这两种症状。如果症状轻微,可以通过改变压力、生活方式和饮食来控制。另一方面,严重的症状可以通过药物和咨询来治疗。

亚太地区已采取许多措施来遏制导致 COVID-19 的新型冠状病毒的传播。这些措施扰乱了包括医疗保健行业在内的各个行业许多公司的运营。员工隔离、供应链故障和需求减少给企业带来了严重的麻烦。此外,私立连锁医院的住院和门诊护理量也大幅下降。为了缓解医疗保健系统的压力,许多诊所推迟了非关键预约。这种情况阻碍了肠易激综合症(IBS)治疗的增长。

肠易激综合症(IBS)治疗市场的利润丰厚的地区


市场洞察

肠易激综合症及相关疾病的患病率不断增加

肠易激综合症是一种主要观察到的慢性胃肠道疾病,由肠易激综合症引起由于排便习惯紊乱和腹痛。该病也称为痉挛性结肠、结肠激惹、粘液性结肠炎和痉挛性结肠炎。肠易激综合症表现为腹痛、便秘、腹泻和痉挛等症状。各地区的卫生系统中肠易激综合征的发病率大幅上升。国际胃肠道疾病基金会公布的数据表明,在所有IBS患者中,约40%的患者患有轻度IBS,约35%患有中度IBS,估计25%患有重度IBS。许多人不认识肠易激综合症的症状。

某些因素,如食物过敏、肠胃炎发展阶段、结肠不时运动、结肠中血清素成分异常以及轻度乳糜泻等,都是可能导致IBS的危险因素。预计这些因素将加速全球 IBS 的患病率。例如,根据 NCBI 2018 年发表的一项研究,IBS 预计每年影响约 10% 至 16% 的美国人口。 IBS 如此惊人的患病率可能会在预测期内推动肠易激综合征 (IBS) 治疗市场的发展。

基于类型的见解

根据类型,肠易激综合症 (IBS) 治疗市场细分为混合 IBS (IBS-M) 、IBS 伴腹泻(IBS-D)和 IBS 伴便秘(IBS-C)。 2020年,混合IBS(IBS-M)细分市场占据最大市场份额。此外,预计同一细分市场在预测期内复合年增长率最高。女性和男性中IBS患病率的上升预计将推动对治疗便秘和腹泻联合症状的药物的需求。 IBS 在老龄化人群中的患病率更高。因此,在预测期内,治疗混合性 IBS 的药物需求可能会显着增长,

肠易激综合症 (IBS) 治疗市场(按类型) 2020年和2028年

基于产品的见解

根据产品,肠易激综合征(IBS)治疗市场细分为利福昔明、eluxadoline、鲁比前列酮、利那洛肽等。利那洛肽细分市场在 2020 年占据最大市场份额。此外,预计同一细分市场在预测期内的复合年增长率最高。该细分市场的增长归因于利那洛肽仿制药产量的增加以及利那洛肽治疗 IBS 的开发和商业化市场整合的不断加强等因素。

基于分销渠道的洞察

根据分销渠道,肠易激综合症(IBS)治疗市场分为医院药房、药店和零售药房以及网上药房。 2020年,医院药房细分市场占据最大份额。然而,药店和零售药房领域预计在预测期内复合年增长率最高。

战略见解

肠易激综合症 (IBS) 治疗市场的公司采用产品创新战略来满足世界各地不断变化的客户需求,这也使他们能够在全球市场上保持自己的品牌声誉。

肠易激综合症(IBS)治疗市场 –按类型

  • 腹泻型肠易激综合症 (IBS-D)
  • 便秘型肠易激综合症 (IBS-C)
  • 混合型肠易激综合症 (IBS-M)< /li>

肠易激综合症 (IBS) 治疗市场 –按产品

  • 利福昔明
  • Eluxadoline
  • 利那洛肽
  • 鲁比前列酮
  • 其他
  • < /ul>

    肠易激综合症 (IBS) 治疗市场 –按分销渠道划分

    • 医院药房
    • 药店和零售药房
    • 网上药房

    肠易激综合症(IBS) 治疗市场&nd;按地理位置

    • 北美洲
      • 美国
      • 加拿大
      • 墨西哥
    • < li>欧洲
      • 法国
      • 德国
      • 意大利
      • 英国
      • 西班牙
      • 休息欧洲
    • 亚太地区 (APAC)
      • 中国
      • 印度
      • 韩国
      • 日本
      • 澳大利亚
      • 亚太地区其他地区
    • 中东和非洲 (MEA)
      • 南非
      • 沙特阿拉伯
      • 阿联酋
      • MEA其他地区
    • 南美洲和中美洲(SCAM )
      • 巴西
      • 阿根廷
      • 其他骗局

    公司简介

    • Ironwood Pharmaceuticals, Inc.
    • AbbVie。
    • Sebela Pharmaceuticals, Inc.
    • 武田制药有限公司
    • Alfasigma SpA
    • 安斯泰来制药公司
    • 阿斯利康
    • 合成生物制剂公司
    • 博士伦公司
    • < li>兰尼特公司
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is irritable bowel syndrome (IBS) treatment?

Irritable bowel syndrome (IBS) is a common disorder that affects the abdominal organ, large intestine. It is also known as spastic colon, mucous colitis, irritable colon, and spastic colitis. The condition is much different than inflammatory bowel disease. However, it is a chronic condition which a person must manage for a longer period. It shows symptoms such as cramping, abdominal pain, bloating, gas, and diarrhea or constipation, or both at the same. These symptoms can be managed by changing stress, lifestyle, and diet. And the more severe symptoms are treated with medication and counseling.

What are the driving factors for the irritable bowel syndrome (IBS) treatment market across the globe?

The factors that are driving growth of the market are increasing prevalence of irritable bowel syndrome diseases and increasing research & development activities.

Who are the major players in the irritable bowel syndrome (IBS) treatment market?

The irritable bowel syndrome (IBS) treatment market majorly consists of the players such as Ironwood Pharmaceuticals, Inc., AbbVie., Sebela Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Alfasigma S.p.A., Astellas Pharma Inc., AstraZeneca, Synthetic Biologics, Inc., Bausch + Lomb Incorporated and Lannett Company Inc amongst others.

The List of Companies - Irritable Bowel Syndrome (IBS) Treatment Market

  1. Ironwood Pharmaceuticals, Inc.
  2. AbbVie.
  3. Sebela Pharmaceuticals, Inc.
  4. Takeda Pharmaceutical Company Limited
  5. Alfasigma S.p.A.
  6. Astellas Pharma Inc.
  7. AstraZeneca
  8. Synthetic Biologics, Inc.
  9. Bausch + Lomb Incorporated
  10. Lannett Company Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports